Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL4167461

CC(C)(CS(=O)(=O)O)N(Cl)Cl.CCCC[N+](CCCC)(CCCC)CCCC

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.40
SLC22A2 O15244 1/20 0.35
TP53 P04637 2/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP3A4 P08684 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
ALOX12 P18054 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HIF1A Q16665 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
GRK2 P25098 1/20 0.32
KMT2A Q03164 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
DNM1 Q05193 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Auriclosene SCHEMBL1537304 0.80
Tetrabuthylammonium SCHEMBL331004 0.75 SLC22A1 (0.63) SLC22A1SLC22A2TP53ALDH1A1CYP3A4
SCHEMBL17023004 0.74 SLC22A1 (0.50) SLC22A1SLC22A2TP53ALDH1A1CYP3A4
Tetrabuthylammonium SCHEMBL4167459 0.73 SLC22A1 (0.40) SLC22A1SLC22A2TP53ALDH1A1CYP3A4
Tetrabuthylammonium SCHEMBL27990806 0.73 SLC22A1 (0.67) SLC22A1SLC22A2TP53ALDH1A1CYP3A4
Tetrabuthylammonium SCHEMBL243899 0.73 SLC22A1 (0.67) SLC22A1SLC22A2TP53ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL3246931 0.73 SLC22A1 (0.48) SLC22A1SLC22A2TP53ALDH1A1CYP3A4
SCHEMBL17022996 0.72 SLC22A1 (0.46) SLC22A1SLC22A2TP53ALDH1A1CYP3A4
SCHEMBL330865 0.72 SLC22A1 (0.62) SLC22A1SLC22A2TP53ALDH1A1CYP3A4
Tetrabuthylammonium SCHEMBL331036 0.71 SLC22A1 (0.63) SLC22A1SLC22A2TP53ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090197838-A1 ANTIMICROBIAL N-HALOGENATED AMINO ACID SALTS ALCON RESEARCH, LTD. (US) 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090197838-A1 ANTIMICROBIAL N-HALOGENATED AMINO ACID SALTS BCAT1, SLC6A15, SLC38A7 SLC22A1 1073/4885SLC22A2 1321/4885TP53 1498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.